The ability to create thick tissues is a major tissue engineering challenge, requiring the development of a suitable vascular supply. Current trends are seeing the utilization of cells seeded into hybrid matrix/scaffold systems to create in vitro vascular analogues. Approaches that aim to create vasculature in vitro include the use of biological extracellular matrices such as collagen hydrogels, porous biodegradable polymeric scaffolds with macro-and micro-lumens and micro-channels, co-culture of cells, incorporation of growth factors, culture in dynamic bioreactor environments, and combinations of these. Of particular interest are those approaches that aim to create bioengineered tissues in vitro that can be readily connected to the host's vasculature following implantation in order to maintain cell viability.
Introduction The Thick Tissue Dilemma
As defined by the National Science Foundation, "Tissue engineering is an interdisciplinary field that applies the principles of engineering & the life sciences towards the development of biological substitutes that restore, maintain or improve tissue function." (Skalak and Fox, 1988) . A critical obstacle in tissue engineering is the inability to maintain large masses of living cells upon transfer from the in vitro culture conditions into the host in vivo. In vivo most cells do not survive more than a few hundred micrometers from the nearest capillary, due to diffusion limitations (Frerich et al., 2001; Okano and Matsuda, 1998; Sheridan et al., 2000) . Capillaries, and the vascular system, are required to supply essential nutrients, including oxygen, remove waste products and provide a biochemical communication "highway" (Cassell et al., 2002; Eiselt et al., 1998; Nerem et al., 1998; Nguyen and D'Amore, 2001; Nomi et al., 2002; Secomb and Pries, 2002) . The circulatory system also contributes to the control of temperature and pressure/perfusion through vasoconstriction and vasodilation. The cardiovascular system is also the earliest to develop in the embryo (Auerbach and Auerbach, 2002; Nguyen and D'Amore, 2001 ) and the establishment and maintenance of a vascular supply is an absolute requirement for the growth of both normal and neoplastic tissues (Auerbach and Auerbach, 2002; Gridley, 2007) . All tissues and organs (with the exception of a minority of tissues such as cartilage) need to be vascularised to be able to survive. Generating a vascular supply to a thick tissue-engineered construct remains a major challenge (Griffith et al., 2005; Grikscheit and Vacanti, 2002) : new blood vessels take days to develop (Griffith and Naughton, 2002) which can lead, for example, to predisposed ischaemia (Grounds, 2000) . This review will examine the process of vascularisation in vivo and then explore the current methods of vascularising bioengineered tissues and organs in vitro, which include the use of microvascular cells and co-culture, and biological and synthetic scaffolds, and explore a novel approach to creating a vascularised tissue analogue in vitro.
the two (Cassell et al., 2002; Nguyen and D'Amore, 2001) , with the main target vessels for angiogenic stimuli being the post-capillary venules and the small terminal venules.
The angiogenic process requires close interactions between the extracellular matrix (ECM), cells and growth factors to produce the required neovascularisation (Cassell et al., 2002) . There are six basic steps in angiogenesis: vasodilation, basement membrane degradation, adherent cell migration, formation of capillary lumen, synthesis of basement membrane, and recruitment of pericytes and vascular smooth muscle cells (Ahrendt et al., 1998; Auerbach and Auerbach, 2002; Cassell et al., 2002; Downs, 2003; Egginton and Gerritsen, 2003; Folkman and Haudenschild, 1980; Jain et al., 1997; Nomi et al., 2002; Norrby, 1997; Vailhe et al., 2001) .
The vasculogenesis process, like the angiogenesis process, can be divided into six steps (Auerbach and Auerbach, 2002; Nomi et al., 2002; Vailhe et al., 2001 ):
1. The in situ differentiation of mesodermal cells into angioblasts or hemangioblasts. 2. EC are generated from precursor cells (angioblasts). 3. EC form the vessel primordia and aggregates that establish cell-to-cell contact but have no lumen. 4. A nascent endothelial tube is formed, composed of polarized EC. 5. A primary vascular network is formed from an array of nascent endothelial tubes. 6. Pericytes and vascular smooth muscle cells are recruited. Figure 1 illustrates the key processes involved in tubule formation and vascularisation of tissues in animals (Kannan et al., 2005) .
Once vessels are made, remodelling of the vascular network occurs in response to the physiological demands of the system. Remodelling of the vascular system involves changes in lumen diameter and wall thickness to suit local needs (Cassell et al., 2002) and can occur though differentiation of the microvascular wall. Differentiation of the microvascular wall can be related to (1) mechanical factors, primarily the blood hydrostatic pressure that acts on arterioles, and (2) metabolic factors related to the local metabolic needs of tissues and reflected in peculiarities of blood-tissue exchange vessels (capillaries and small venules) (Slaaf et al., 1993) . Intussusceptive microvascular growth (IMG) is a concept of vascular morphogenesis and remodelling that provides an alternative mechanism to angiogenesis by endothelial sprouting. IMG refers to partitioning of the perfused vessel lumen by the insertion of interstitial (or intervascular) tissue structures or tissue pillars. This is followed by growth of these structures resulting in network expansion. IMG is also an important mechanism of vascular network remodelling, defined as rearrangement of the number and/or position of vascular segments without significant network expansion (Jain et al., 1997; Patan et al., 2001) . IMG, however, has not been observed so far in vascular analogue tissue engineering research. So in order to identify an in vitro bioengineered vascular analogue as functional, the created vasculature has to be able to respond to both mechanical and metabolic factors.
Blood vessel structure
The smallest microvessels are the capillaries with an inner diameter of 4-10µm and a very thin wall of EC. The wall thickness of microvessels can be as much as half the luminal diameter. The boundary between arteriole and capillary is marked by the disappearance of smooth muscle cells (SMCs). The arterioles represent the major site of Figure 1 . The relationship between the various pathways to vessel development. Adapted from (Kannan, et al., 2005) .
resistance to and regulation of local blood flow, with arterioles varying in diameter from 10µm to 300µm, with one or two layers of SMC helically arranged in the media, with the inner lining consisting of endothelium (Slaaf et al., 1993) . However the transition from capillary to venule is less well defined and occurs gradually. The immediate post-capillary venules range in diameter from ~10-50µm and initially lack SMC in their walls. They drain into collecting venules, the diameter of which gradually increases from ~50-300µm (Slaaf et al., 1993) .
Large vessels are separate anatomical entities, whereas microvessels are structurally and functionally part of the tissue they supply for which the input for the microcirculation of tissues is small arteries (Slaaf et al., 1993) . Immature endothelial-lined tubes that arise during vasculogenesis and angiogenesis subsequently differentiate into capillaries (after association with pericytes) or into larger vessels such as arteries and veins (after forming a media composed essentially of SMC).
Generation of vascular structures
Traditionally, research on vascularisation has relied on animal models to observe and understand the process (Norrby, 2006) . Various models exist such as the chorioallantoic membrane model (Borges et al., 2003b) and the disc angiogenesis system (Kowalski et al., 1992) , as well as the analysis of the expression of various factors associated with vascularisation after implantation of scaffolds into animals such as mice (Vallien et al., 2000) .
There has been some success in creating vascular analogue scaffolds and precursor tissues in vivo. Implanted cell-seeded constructs in animals have acted as living bioreactors for cells within scaffolds, and models of vascularisation in animals (Cassell et al., 2002; Koike et al., 2004) have included adapted chorioallantoic membrane (Borges et al., 2003a) , porcine (Schultheiss et al., 2005) , mice (including nude mice) (Koike et al., 2004; Okano and Matsuda, 1998; Sieminski et al., 2002) , and immunodeficient mouse (Nor et al., 2001 ) models.
Ischemia has also been shown to stimulate vascularization. Circulating endothelial progenitor cells (EPCs) have been mobilized endogenously in response to tissue ischemia or exogenously by cytokine therapy and seem to augment neovascularization of ischemic tissues (Takahashi et al., 1999) . Circulating mononuclear cells in human peripheral blood have been shown to be incorporated into foci of neovascularization, consistent with postnatal vasculogenesis. In experiments, the development of regional ischemia in both mice and rabbits increases the frequency of circulating EPCs (Takahashi et al., 1999) .
Vascular Analogues In Vitro
Creation of vascular networks and mass transfer considerations The question of whether vascularisation can occur in vitro without a blood supply is an important one. From a functionality viewpoint, if we define a bioengineered vessel as being viable when it can mimic everything a natural vessel does in vivo, then we are currently disappointingly short of that ideal target. Currently in biological and synthetic scaffolds, in vitro formation of multi-branching networks of cells (Kaihara et al., 2000; Wu et al., 2004) , lumens (Egginton and Gerritsen, 2003; Sieminski and Gooch, 2004; Sieminski et al., 2004) , contiguous vessel walls (Black et al., 1998) , and responsiveness to chemical and biophysical signals (Lee et al., 2000) , have been observed. But nothing so far has been able to compare to the effectiveness and quality of microvascular network formation in vivo (Borges et al., 2003a; Patan et al., 2001) . This may be due in part to the complex combination of biochemical signals in blood and the biophysical influences that accompany blood flow (Lee and Schmid-Schonbein, 1995; Pries and Secomb, 2002) . Unless we are able to elucidate and simulate the complex biochemical cocktail in blood, as well as the biophysical environment during blood flow, we may well need a blood supply to create a functional microvascular system.
Pre-capillary and vessel networks can occur in various forms in vitro and on various substrates and materials (Kannan et al., 2005; Moldovan and Ferrari, 2002; Vailhe et al., 2001) . Two regulatory pathways have been proposed by which angiogenesis is thought to proceed. The proliferative pathway depends on various cytokines and other factors that both stimulate and inhibit the proliferation of EC. The morphogenetic pathway depends on the synthesis and assembly of fibrillar type 1 collagen, which can be used as a template for EC migration and lumen formation. EC interact with substrates of type 1 collagen and form networks based on the establishment of traction centres. These planar cellular networks, in some respects, resemble developing vasculature in vivo (Sage and Vernon, 1994) .
The use of microvascular EC (MVEC), the key cells for vascularisation in the body, for angiogenesis in vitro was demonstrated in 1980 (Folkman and Haudenschild, 1980) and subsequently by others (Bachetti and Morbidelli, 2000) . Some groups have been able to reconstruct semivascularised bioengineered tissues and equivalents in vitro, including "vascularised" skin (Black et al., 1998; Germain et al., 2000; Tonello et al., 2003) , while other groups have created cell models for vascularisation and capillarynetwork formation to study various cell-cell, cell-matrix (Sieminski et al., 2004) and cell-nutrient diffusion interactions (Griffith et al., 2005) .
There has been much work done on creating functional macrovessels using bioreactors that utilize perfusion and mechanical stimulation (Barron et al., 2003; Jeong et al., 2005; McCulloch et al., 2004; Mironov et al., 2003; Niklason et al., 2001; Niklason et al., 1999; Stegemann and Nerem, 2003; Thompson et al., 2002) . There is no doubt that bioreactors are essential for the in vitro creation of functional and viable tissues and vessels (Freed and Vunjak-Novakovic, 2002; Martin et al., 2004; Niklason and Seruya, 2002) . For microvascular applications, some groups have created microvessels using perfusion bioreactor technologies (Neumann et al., 2003) , while others have used horizontal rotating bioreactors, such as the one developed by NASA (Dutt et al., 2003) .
A traditional research area for investigating the functionality of microvessels has been the use of the eye system, for example in the diabetic retinopathy field. The modulation of the transport barrier of MVEC (Haselton et al., 1996) is definitely one of the defining functions of the microvasculature. Functional responses to ischemia could be simulated in culture environments to influence arteriogenesis, collateral vessel formation, and increase blood vessel density once bioengineered tissues are vascularised (Helisch and Schaper, 2003) .
However, comprehensive vascularisation of thick tissues in vitro is hard to control and reproduce reliably. From this point there is the next limitation of creating proper connections of the bioengineered tissue with host vasculature when the tissue is implanted.
Cell Types for In Vitro Vascular Analogues

Microvascular and macrovascular endothelial cells
In tissue engineering vasculature, stabilization of capillarylike structures (CLS) is of utmost importance (Frerich et al., 2001) . Endothelium is most important in the microcirculation, where exchange of gases, fluids, nutrients, and waste products occurs. The endothelia of capillaries most commonly exist as a continuous sheet, but also can take the form of a sheet with fenestrations (in small intestines, endocrine glands, and kidneys), or as a discontinuous sheet (in sinusoids of the liver) (Nguyen and D'Amore, 2001; Sumpio et al., 2002) .
Permeability regulation is important for microvessels and capillaries (Haselton et al., 1996; Hellstrom et al., 2001; Nguyen et al., 2001; Sumpio et al., 2002) . Fenestrations, caveolae, and pores are at the level of the EC soma as well as gaps between EC. Fenestrations are specialised areas of the EC plasma membrane that are involved in permeability, and fenestrated endothelia are found in microvessels associated with secretory and absorptive epithelia, such as kidney glomeruli, endocrine organs, and the gastrointestinal tract (Nguyen et al., 2001; Sumpio et al., 2002) . In contrast, EC found in connective tissues, skin, muscle, lung, and brain have few, if any fenestrations (Nguyen et al., 2001) .
Endothelial cells exert significant paracrine and endocrine actions through their influence on the underlying SMC or on circulating blood elements, such as platelets and white blood cells (Sumpio et al., 2002) . EC are normally quiescent in vivo and most in adults have a cell cycle variable from months to years. However, following an injury, cells change their phenotype, migrate and proliferate to heal lesions in a few days (Bachetti and Morbidelli, 2000) .
EC also play direct roles in controlling the vascular tone, blood flow and vascular permeability, especially in the microvasculature (Bachetti and Morbidelli, 2000) . Various types of EC such as human umbilical vein EC (HUVEC) (Tonello et al., 2003) , rat microvascular EC (Frye and Patrick, 2002) , human dermal microvascular EC (HDMEC) (Borges et al., 2003a; Nor et al., 2001; Richard et al., 1998) , bovine aortic EC (BAEC) (Dutt et al., 2003; Vernon et al., 1995) and bovine capillary EC (BCEC) have been used for in vitro models of angiogenesis and vasculogenesis (Karasek, 1989; Vailhe et al., 2001) . The immortalised HMEC line SV-40 HMEC-1 has also been used (Ades et al., 1992; Liu et al., 2002; Meade-Tollin and Van Noorden, 2000) . Gelatin, fibrin, collagen, fibronectin (Harding et al., 2002) and Matrigel (MeadeTollin and Van Noorden, 2000) have been used as matrices for 2D and 3D culture studies. It has been noted though that cultured EC rapidly undergo apoptosis following implantation in vivo (Nomi et al., 2002) .
The biochemical profile of microvascular and macrovascular EC differ, indicating system-specific functions and roles. For example the matrix metalloproteinases (MMP) and tissue inhibitor of metalloproteinases (TIMP) secretory profiles of cultured microvascular compared to macrovascular tissues is different (Jackson and Nguyen, 1997) . For example cytokeratin 8, 18, 19 and vimentin are cytoskeletal proteins that are present on microvascular EC but not on macrovascular EC (Bachetti and Morbidelli, 2000) . The ECM components produced by microvascular EC and macrovascular EC are different, and are linked to the different thrombogenic properties of the cells (Bonnefoy et al., 2001) . On a wider application focus, there are differences in phenotype expression between primary cells and cell lines as well (Unger et al., 2002) .
Interaction of endothelial cells with smooth muscle cells
Even though SMC are not typically associated with capillaries, endothelial progenitor cells (EPC) have been co-cultured with SMC to form microvessels on porous polymer scaffolds in vitro (Wu et al., 2004) and it has been reported that rat aortic SMC can become pericyte-like during angiogenesis in vitro (Nicosia and Villaschi, 1995) . It has also been reported that, like EC, vascular SMC can display blood vessel formation behavior in vitro when an appropriate 3D matrix environment is provided to keep them in a relatively higher-differentiated and lowproliferative state (Song et al., 2000) . An artificial method to induce migration, and potentially CLS formation, of EC has been to co-culture EC with VEGF-transfected SMC or their conditioned media (Elbjeirami and West, 2006) . The significance of these observations for tissue engineering is that SMC may be used in bioengineering microvascular networks. However, the importance and biological relevance of SMC over pericytes remains to be determined since pericytes are the key supporting cells in microvascular networks in vivo.
Pericytes
The origin of cells may be an important factor when utilizing cells for specific tissues, and it is important to use cells with the correct phenotype (Jackson and Nguyen, 1997) . For undifferentiated cells though, this may not be the case. For example, pericytes have been suggested to have tissue-specific functions (Hirschi and D'Amore, 1996) . Although tissue-specific cell functions can be shown from cells that display plasticity, as has been demonstrated Vascularisation when engineering thick tissues by various "tissue-specific" cell types (Rezai et al., 2004; Tao and Ma, 2003) .
Pericytes, also known as Rouget cells or mural cells, are the microvascular correlates of SMC, lie within the basement membrane and have processes that reach through to contact the EC (Hirschi and D'Amore, 1996; Thomas, 1999) . Morphologically, pericytes exhibit a small, oval cell body with multiple processes extending for some distance along the vessel axis. These primary processes then give rise to orthogonal secondary branches which encircle the vascular wall. Pericytes are precisely located adjacent to or over EC junctions of venules and especially over gaps between EC during inflammation (Sims, 2000) . Of functional importance, it has been reported that pericyte inclusion in in vitro capillary permeability experiments increases the capillary barrier effect (Dente et al., 2001) .
Perivascular cells (pericytes and SMC) stabilise newly formed capillaries and render them to matured structures (Hirschi and D'Amore, 1996) . Pericytes are most abundant in venules, and common in capillaries (Nguyen et al., 2001; Sims, 2000) , and are suggested to be oligopotential and reported to differentiate into adipocytes, osteoblasts, macrophages, and phagocytes (Hirschi and D'Amore, 1996; Thomas, 1999) . Microvessel pericytes seem to exhibit several oxygen dependent, phenotypic characteristics ascribed to osteoblasts (Reilly et al., 1998) . However, they are absent from growing vessels, implying a role in down-regulating EC proliferation (Cassell et al., 2002) . Vessels that are associated with pericytes persist independently of VEGF, whereas those lacking pericytes regress following VEGF withdrawal (Carmeliet and Conway, 2001; Carmeliet and Luttun, 2001) .
The pericyte population is highly variable between different tissues and organs, likely influenced by postarteriolar hydrostatic pressures, and are more abundant in the distal legs and feet, suggesting a hydrostatic pressuredriven mechanical role for pericytes as protectors of microvessel wall integrity (Sims, 2000) . This implies a major role for perivascular mesenchymal cells for the stabilization of newly formed vascular structures, and that the use of perivascular cells is likely to be beneficial for in vitro vascular bed systems, and to help create and maintain a functional in vitro vascular bed template. Pericytes may also function as macrophages, amongst other functional roles. They can be contractile and seem to serve as a smooth muscle equivalent in the capillaries performing vasoconstriction, and they appear to directly participate in coagulation through the extrinsic pathway (Thomas, 1999) .
It has also been seen in vivo that monocytes and macrophages can have the propensity for endothelial transdifferentiation within Matrigel and may have a role in formation of CLS (Anghelina et al., 2006a; Anghelina et al., 2006b ).
Stem cells & bone marrow stromal cells (BMSC)
Bone marrow-derived cells have been reported to induce repair of tissue in vivo (Zantop et al., 2006; Zhou et al., 2007) . For vascularisation and re-vascularisation purposes, precursor cells, such as endothelial precursor cells, have been used to study angiogenesis (Laing et al., 2007a; Laing et al., 2007b; Otani et al., 2002) . BMSC have been used for therapeutic angiogenesis in animal research for many years (Choong et al., 2006; Kaigler et al., 2006a; Kruyt et al., 2007; Short et al., 2003; Zhou et al., 2007) . These can form blood vessel-like structures consisting of endothelial tubes supported by SMC in 3D matrix gels and in chick embryo models (Nomi et al., 2002) , retinal precursor cells in ocular angiogenesis experiments (Dutt et al., 2003) , and EPC for in vivo ocular disease models (Otani et al., 2002) .
Adult bone marrow (BM) contains cells capable of differentiating along hematopoietic (Lin(+)) or nonhematopoietic (Lin(-)) lineages. Lin(-) hematopoietic stem cells (HSCs) have been shown to contain a population of EPC capable of forming blood vessels (Otani et al., 2002) . In neonatal mouse eye experiments, Lin(-) BM cells and astrocytes specifically interact with one another during normal angiogenesis and pathological vascular degeneration in the retina, and are extensively and stably incorporated into the forming retinal vasculature (Otani et al., 2002) .
Current data suggest stromal progenitors in the BM in situ are associated with the outer surfaces of blood vessels and may share identity with vascular pericytes (Short et al., 2003) . In adult organisms, BM-derived cells do not promote vascular growth by incorporating into vessel walls but may function as supporting cells (Ziegelhoeffer et al., 2004) . The major contribution of BM cells to angiogenic processes is not endothelial, but may come from progenitors for periendothelial vascular mural and hematopoietic effector cells (Rajantie et al., 2004) .
Autologous BMSC implantation in a chronic hind limb ischemia model in rats seems to induce a neo-vascular response resulting in a significant increase in blood flow to the ischemic limb, as well as spontaneously regenerating the various components of muscular tissues (Al-Khaldi et al., 2003) . Use of BMSC and EC in scaffolds has seen the regeneration of osseous defects (Kaigler et al., 2006a) . The relevance to vasculogenesis of these observations is that use of BMSC would have benefits for both vascularisation and whole tissue and organ regeneration because BMSC could be used for vascularisation and organ tissue growth. EPC as well as other BM-derived cells have been shown to contribute to the growth of endotheliumlined vessels (angiogenesis) as well as the expansion of pre-existing collaterals (arteriogenesis) in ischemic disease (Carmeliet and Luttun, 2001 ). In another study, the microvessel density in ischemic hindlimbs in mice was significantly higher in CD117+ cell-implanted mice than in the total BM cell-implanted mice, and implicated as playing a key role in therapeutic angiogenesis induced by BM cell implantation .
Other BM-derived cells such as BM-derived fibroblasts and BM endothelial cells have been used in 3D scaffold cultures with the aim of stimulating vascularisation and tissue formation (Choong et al., 2006; Srouji et al., 2006) .
Co-culture
The interaction of EC with other cell types in vivo has been seen to promote and maintain vascularisation. The aim of using co-culture is to mimic the beneficial and complex interactions between cells to create and maintain vascularisation in vitro. However, the optimal combination of cells, their ratios, and conditions are still unknowns.
When blood vessels grow, EC migrate out first and assemble in a primitive network of immature channels (angiogenesis). These nascent vessels only consist of EC, and they rupture easily and are leaky, prone to regression, and poorly perfused. If perfusion is to become functional, the network must remodel into a vascular tree of mature large vessels branching off into smaller capillaries, whereby excess immature vessels are pruned. The recruitment of periendothelial cells (PEC) (pericytes in small vessels or SMC in larger vessels) around nascent vessels essentially contributes to the remodelling and maturation of the primitive vascular network (arteriogenesis) (Dente et al., 2001; Hirschi and D'Amore, 1996; Sims, 2000) . When PEC make contact with EC, the EC stop dividing and migrating, and EC become quiescent, acquire specialised differentiation properties, and survive for longer (Carmeliet and Conway, 2001; Sims, 2000) . PEC stabilize vessels by producing ECM and tightening junctions, regulating perfusion through vasomotion, establish vascular barriers, and make vessels more resistant to regression (Thomas, 1999) , and they also help to establish vascular branches and prevent aneurysmal vessel dilation. PEC help to establish a more mature, functional vascular network and are therefore targets for inducing therapeutic angiogenesis (Carmeliet and Conway, 2001 ).
In co-culture studies of BAEC and human astrocytes, regulation of extracellular angio-associated migratory cell protein (AAMP) by astrocytes has been hypothesized to aid in angiogenesis of the nervous system (Beckner et al., 2002) .
Microvascular EC can also be used for other purposes. Porcine brain microvascular EC have been used to support the in vitro expansion of human primitive hematopoietic BM progenitor cells via cell-to-cell interactions and colony-stimulating factors (Davis et al., 1995) . These examples highlight the complex roles that microvascular cells play in vascular biology. It is therefore foreseen for in vitro applications that the interactions between different cell types in co-culture may provide beneficial cues for forming stable vessels and tissues.
Additional questions for co-culture utilization for vascularisation in vitro are not simply questions about cellcell interactions or cell-matrix interactions, but in situations involving synthetic scaffolds, are the interactions and behaviours of co-cultures with the scaffold material surface (Choong et al., 2006) . Fibroblasts are another cell type that has been used in co-culture. Fibroblasts not only function to sustain various organs and tissues as stroma cells but also act directly to regulate adjacent cell behavior including migration, proliferation, and differentiation. In vitro results in collagen hydrogels suggest that fibroblasts secrete soluble factors that can influence EC behaviours relevant to the angiogenesis process with possible implications for vascularization in fibroproliferative conditions (Kuzuya and Kinsella, 1994) . Without the necessary survival signals, EC suspended in 3D gels in vitro die, but the presence of non-EC improves, for example, the survival of BAEC embedded within Matrigel (Sieminski et al., 2002) . EC have been shown to elongate and form microvascular networks along lines of ECM tension in fibroblast-containing culture gels (Sieminski et al., 2002) , and culture of BAEC with fibroblasts causes them to elongate and enhance their survival in vitro compared to control cultures without any other cells. A mechanism for improved cell survival has been hypothesized to be the direct physical contact between BAEC and the fibroblasts (Kuzuya and Kinsella, 1994; Sieminski et al., 2002) . In a further example, in a disc angiogenesis model with EC and fibroblasts, angiogenesis is observed (Kowalski et al., 1992) , and the results support the need for co-culture for effective cell functioning.
Dermal fibroblasts are reported to produce angiogenic growth factors (Griffith and Naughton, 2002) . BAEC cocultured in collagen hydrogels with human skin fibroblasts cause the EC to become spindle shaped and to organize into a CLS within the collagen hydrogels. Interestingly, fibroblast-conditioned medium also induces EC initially to elongate and subsequently to organize into a CLS within collagen hydrogels (Kuzuya and Kinsella, 1994) . In endothelialized skin equivalents, collagen biopolymer cocultured with human keratinocytes, dermal fibroblasts, and umbilical vein EC have spontaneously formed CLS in a highly differentiated ECM (Black et al., 1998) . In vivo, culture of human dermal microvascular EC (HDMVEC) spheroids and preadipocytes in a fibrin matrix for a specially adapted chorioallantoic membrane model have resulted in vascularisation of the matrix, with a capillary network forming consisting of the transplanted HDMVEC (Borges et al., 2003b) . However, some other tissues have not experienced the same success, such as creating muscle tissue with an in vivo pre-vascularised fibrin matrix (Bach et al., 2006) . For potential neuro-regeneration applications, neurons and glioma cells have been seen to over-express stem-cell factor which induces angiogenesis in vitro and in vivo in response to tumour-induced brain injury (Thomas, 2006) . Scaffold-free multi-cell artificiallycreated microtissues using combinations of myoblasts, chondrocytes, myofibroblasts, cardiomyocytes and HUVEC have been implanted in vivo and have developed a vascular system (Kelm et al., 2006a; Kelm et al., 2006b ). This approach further illustrates the viability of utilizing complex multiple cell types in the pursuit of creating viable tissue engineered tissues.
Approaches to vascularising scaffolds
Vascularisation of new bioengineered tissue can be accomplished in three ways. Upon implantation, vessels from surrounding tissue can be induced to infiltrate the tissue with such vessel growth promoted by including growth factors in the polymer scaffold. These factors diffuse into the local environment, where they encourage existing blood vessels to grow into the scaffold with cells growing in from both sides knotting together to form a continuous vessel (Kannan et al., 2005; Sheridan et al., 2000) . But this approach is problematic as blood vessels need time to infiltrate into tissues, and thereby this will Vascularisation when engineering thick tissues predispose the tissue to ischemia as the cells wait for a nutrient supply to reach them. Vessels may also grow from within a scaffold seeded with EC to help enhance the rate of vascularisation. This approach is based on the hypothesis that the transplanted cells will form CLS and join with inwards growing vessels from the host tissue and combine with existing blood vessels to create a continuous vessel (Kannan et al., 2005; Sheridan et al., 2000) . This approach is also associated with a time delay before vascular perfusion can occur due to the time for the vessel network within the scaffold to anastomose with the host vasculature. There is also a third method where matrices are prevascularised in vivo (Lokmic et al., 2007; Polykandriotis et al., 2006; Polykandriotis et al., 2007) , and though this review focuses on in vitro methods it is important to apply in vivo results and observations to in vitro applications.
Use of three-dimensional scaffolds
With the possible exception of blood, three-dimensional (3D) scaffolds are essential for creating realistic tissues and organs for regenerative medicine. Tissues exist as 3D structures, but the traditional approach of growing cells in tissue culture flasks is far removed from the in vivo situation. Cells in vitro proliferate at a liquid/substratum interface and primary tissue cells grown in tissue culture flasks experience contact inhibition. This severely limits the degree of total cellularity of the system (Long, 2000) .
Design factors for control of 3D tissue engineering constructs include (1) the required substrate and ECM composition (materials), (2) composition and rates of tissue development (rates), (3) cell types present, localisation and segregation from each other (cell types), (4) tissue shape and microscopic architecture (architecture), and (5) special local tissue functional requirements (Brown, 2000; Chen et al., 2001a) . Some of the other elements to consider are illustrated in Figure 2 (Seal et al., 2001 ).
Synthetic polymer scaffolds
Synthetic biodegradable polymer scaffolds have been a material of choice to create scaffolds to support cell growth for bioengineered tissues and organs because they are more controllable from a compositional and materials processing viewpoint than biological materials. The drawback is that they may not be recognised by cells due to the absence of biological signals. Scaffold architecture parameters such as pore size, porosity, and surface area (surface-to-volume ratio) are widely recognised as important parameters when designing a scaffold (Cao et al., 2006; Mastrogiacomo et al., 2006) . Other structural features such as pore shape, pore wall morphology, and interconnectivity between pores are also important for cell seeding, migration, growth, mass transport, gene expression, and new tissue formation in 3D (Ma and Choi, 2001; Mastrogiacomo et al., 2006; Mikos and Temenoff, 2000) .
To coarsely mimic vasculature, some scaffold designs have incorporated grooves, microchannels and/or orientated pores to aid in directing cell growth and behaviour (Britland et al., 1996; Curtis and Wilkinson, 2001; Kaihara et al., 2000; Shen et al., 2006a; Shen et al., 2006b) . This strategy also extends to biological scaffolds with lumens/channels (Sachlos et al., 2006; Sachlos et al., 2003) . Microchannels in scaffolds and cell culture environments have been used to increase mass transfer of nutrients and cellular metabolic wastes in and out of the cell/scaffold mass (Kaihara et al., 2000; Leclerc et al., 2004c; Sachlos et al., 2003; Shin et al., 2004) , and mathematical modelling has been used to create networks with specific microfluidics and nutritional transfer (Leclerc et al., 2004a; Leclerc et al., 2004c; Radisic et al., 2006) . Channels and microchannel networks not only have applications in vascularising scaffolds and bioengineered tissues (Grikscheit and Vacanti, 2002; Leclerc et al., 2004c) , or simply as blood vessel templates, but are also suited for neural applications in growing peripheral nerves Figure 2 . Some of the biological and engineering design requirements of scaffolds for tissue regeneration. Adapted from (Seal, et al., 2001) . (Sundback et al., 2003) . An application has been to create branching structures of the vascular network following a fractal geometry where it has been observed that EC densities and degree of organisation are higher on scaffolds with higher branching levels, or complexity (Vozzi et al., 2004) .
Soft lithography techniques such as stamps or channels have been used to create scaffolds. Also used are techniques such as self-assembled monolayers, microcontact printing, patterning using microfluidic channels (Kim et al., 1998b) , laser microfabrication (Duncan et al., 2002) and laminar flow patterning (Kane et al., 1999; Leclerc et al., 2004b; Moldovan and Ferrari, 2002) . Benefits of these approaches are the immediate perfusion of living tissue via the integrated "vascular" network, and that these can be used to potentially create "vascularized" layered 3D structures of any shape and size (Kaihara et al., 2000; Vacanti et al., 2003) .
Biodegradable and bioresorbable polymers have been based primarily on clinically established products, such as polylactides, polyglycolides, optically active and racemic polylactides, and polycaprolactone Hutmacher et al., 2001) . But there are other synthetic materials being used including ones that are under clinical investigation for regulatory approval as well as more novel polymeric biomaterials that are being tested in vitro only, such as peptide-based materials (Holmes, 2002) . Disadvantages of cellular solid fabrication methods, using these synthetic polymers, such as solvent leaching, porogen leaching, gas foaming, vacuum drying, and thermally induced phase separation (TIPS) (Chen et al., 2002; are that pores are sometimes not completely inter-connected. Pores may vary in size and the thickness and length of pore walls and edges vary depending on the solvent evaporation rate. The scaffolds cannot be made with thick sections as deeply embedded porogens become too distant from the surface and residual porogen may be left in the final structure . However, with the development of better techniques to ensure porogen connectivity and therefore pore interconnectivity, such as porogen fusion, there has been progress made into creating better cellular solids scaffolds (Murphy et al., 2002) . Alternatively, precise computercontrolled manufacturing methods such as fused deposition modelling can create porous scaffolds (Zein et al., 2002) . This can be used, for example, to create knitted textile scaffolds with specific woven geometries (Wintermantel et al., 1996) .
Biological scaffolds
Biological materials are utilised in tissue engineering due to the fact that there are many beneficial interactions between these materials with cells. Natural materials are readily recognised by cells, but the drawbacks to using these materials include their poor mechanical properties. Interactions between cells and biological ECM are catalysts to cell migration, proliferation, differentiation, and apoptosis, which are all critical functions in tissues (Grikscheit and Vacanti, 2002) . Mechanical strength of tissues derives in a major part from the ECM and production of matrix, and matrix production can be manipulated (Edelman, 1999) . Biomechanical tension between EC and matrix may serve to regulate capillary development since mechanical forces exerted by the cells onto the matrix drive its reorganisation into cords and subsequent CLS formation (Vailhe et al., 2001) .
Collagen is an important ECM molecule (Kleinman et al., 1982) , and is the major structural component in the body, comprising up to 25% of the dry protein (Brown, 2000) . Collagen is an important part of the structure and formation of vasculature, so it makes biomimetic sense to use collagen for bioengineered vascularized tissues. Of interest for in vitro utilization of collagens, types I and IV are equally active both in native and denatured forms (Kleinman et al., 1982) . There are also very few interspecies differences in the structure of type I collagen. The extensive homology of the structure of type I collagen means that when sourced from animal species it is acceptable as a material for human transplantation (Li, 2003) . For tissue engineering applications, collagen hydrogels are formed via fibrillogenesis of soluble collagen and have a random orientation and distribution, producing an isotropic gel (Brown, 2000) . Porous collagen matrices are made by freeze-drying aqueous collagen solutions or dispersions. Freeze-dried matrices require chemical crosslinking to stabilize the structure where the rate of freezing, the size of fibres in the dispersion, and the presence and absence of other macromolecules contribute to the pore structure (Li, 2003) .
Growth factor delivery using collagen hydrogels is another benefit of utilizing this biological material. For example, loading of basic fibroblast growth factor into heparin sulphate-attached (Pieper et al., 2002) or glycosaminoglycan (GAG)-attached (Geutjes et al., 2006) cross-linked collagen matrices has seen improved long term vascularisation of hydrogels in vivo. In mice implantation studies, VEGF incorporation into cross-linked collagen hydrogels has seen significant angiogenesis around implants (Tabata et al., 2000) and into the scaffolds (Nillesen et al., 2007) . Cell delivery using collagen hydrogel has been utilized with, for example, a skeletal muscle cell line and type 1 collagen hydrogel scaffold constructed in vitro and implanted into nude mice to vascularize it in vivo (Okano and Matsuda, 1998) as well as with bone-marrow derived mesenchymal stem cells (BM-MSC) implanted into mice that has shown increased cellularity and vascularisation (Markowicz et al., 2006) . In contrast, viable tissues have also been seen in transplanted un-prevascularised cells in collagen matrices, where EC have rapidly infiltrated the tissue (Zhao et al., 2005) .
The relative magnitudes of cellular force generation and apparent collagen hydrogel matrix stiffness seem to modulate capillary morphogenesis in vitro. This balance may play a role in regulating angiogenesis in vivo. In constrained collagen hydrogels EC have appeared spread, formed structures with fewer cells, had larger, thinnerwalled lumens than in floating (unconstrained) hydrogels, and showed prominent actin stress fibers not seen in floating gels (Sieminski et al., 2004) .
Collagen hydrogels have also been used extensively for engineering macrovessels for cardiovascular applications . Approaches have included the use of cross-linked hydrogels to create mechanically strong vessels (Berglund et al., 2003) , use of SMC cultured in collagen hydrogels (Song et al., 2000; Stegemann and Nerem, 2003a) , ECs co-cultured with SMC (Imberti et al., 2002) , the use of mechanical stimulation regimes, such as cyclical radial distension and/or shear stress, in bioreactors (Braddon et al., 2002; Chappell et al., 1998; Hoerstrup et al., 2001; Imberti et al., 2002; Nerem et al., 1998; Ziegler et al., 1995) , as well as the use of various biochemical growth factors to help create a biomimetic vessel substitute (Imberti et al., 2002; Stegemann and Nerem, 2003b; Stegemann and Nerem, 2003a ). There have also been studies where collagen and fibrin hydrogels loaded with VEGF and exposed to low interstitial fluid flow result in the formation of different CLS structures (Helm et al., 2007) giving rise to the importance of the specific matrix composition on CLS structure.
To influence the structure of collagen hydrogels, cells in collagen hydrogels can be exposed to mechanical uniaxial stimulation to aid in aligning cells and fibres in a certain direction. High density magnetic fields have also been used to align collagen hydrogel fibres during fibrillogenesis (Dickinson et al., 1994; Guido and Tranquillo, 1993) , however, controlling the structure of the collagen hydrogel fibrils at such an early stage has not been conclusively beneficial. This may be because cells, in response to external cues, will respond accordingly to remodel their environment.
Hybrid scaffolds
The need for hybrid natural/synthetic scaffolds stems from the need to meet the demands for a scaffold system that cells respond to favourably as well as being reliably and repeatedly manufacturable to a consistent quality, and have controllable structural and chemical composition for creating bioengineered organs in vitro. These criteria encompass elements such as:
1. a surface that promotes cell adhesion, promotes cell growth and allows the retention of differentiated cell phenotypes, 2. biocompatible, and the by-products should not be toxic or provoke inflammation in vivo, 3. biodegradable, and eventually eliminated from the body, 4. porosity should be high enough to provide sufficient space for cell adhesion, ECM regeneration and allow maximal diffusion during culture, 5. pore structures that allow even spatial cell distribution throughout the scaffold to facilitate homogeneous tissue formation, and 6. the material should be reproducibly processable into 3D structures, and be mechanically strong (Chen et al., 2002) .
The motivation for hybrid natural/synthetic scaffolds has been to combine the benefits of ease of processing, structure control, and relatively good mechanical strength of synthetic polymers, with the benefits of beneficial cell interactions and hydrophilicity of biological matrices like collagen. The most common method of hybridizing collagen with synthetic polymer scaffolds has been to coat the scaffold with a collagen gel that becomes a sponge (Chen et al., 2004a; Chen et al., 2003; Chen et al., 2004b; Chen et al., 2000; Chen et al., 2001a; Chen et al., 2002) . Biological molecules, such as fibronectin (Harding et al., 2002) and VEGF (Elcin and Elcin, 2006; Kaigler et al., 2006b) , have also been used to coat synthetic polymer scaffolds for growing vessels.
Bridging the in vivo / in vitro gap
Concept
For a bioengineered organ to be clinically relevant, it needs to be able to be seamlessly integrated when implanted into the patient. There needs to be a system that prevents cell death due to the changes in perfusion quality during the transferral from an in vitro system (i.e. bioreactor) to the in vivo system (i.e. circulatory system). Currently there are techniques that vascularise pre-shaped tissues in vivo before autologously transplanting to another site on the body (MacLeod et al., 2003; Tan et al., 2004) , but this causes donor site morbidity and so is therefore less than ideal.
To address these issues, we have integrated five elements from current approaches, which have been commonly used separately in the literature, as a novel approach to vascularising tissue analogues in vitro. The first two components are the incorporation of multiple macro-lumens lumens (Kaihara et al., 2000; Leclerc et al., 2004b; Sachlos et al., 2006; Sachlos et al., 2003; Shin et al., 2004) , in porogen-fused, highly porous and interconnected biodegradable synthetic polymer scaffolds (Gao et al., 2006; Murphy et al., 2002) to aid in increasing access to nutrients for cells within the scaffold, as well as creating "vessels" that can be used to connect to host vasculature on implantation. The third component is the use of collagen hydrogel as a cell delivery vehicle into the porous scaffolds. The collagen is also the biological matrix that will support cell growth, migration, and vascularisation behaviour of microvascular cells. Figure 3 illustrates the components of this system, where a porous polymer scaffold is combined with cells and biological matrix to direct cell behaviour and eventual tissue growth. The fourth component is the use of co-cultures of EC with other cell types to investigate the interaction between the various cells, scaffold, and formed microvessels in the system (Beckner et al., 2002; Black et al., 1998; Dente et al., 2001; Imegwu et al., 2001; Kuzuya and Kinsella, 1994 ). An analogue that can be created with co-culture is bone, via the incorporation of BMSC (Choong et al., 2006; Kaigler et al., 2006a; Kruyt et al., 2007; Short et al., 2003; Zhou et al., 2007) . In fact the use of BMSC has been reported to secrete sufficient quantities of VEGF to enhance survival and differentiation of EC in vitro (Kaigler et al., 2003) . The use of BMSC itself has been used for neovascularisation (Kinnaird et al., 2004; Li et al., 2003) 
. Vascularisation when engineering thick tissues
The fifth component is the use of a dynamic culture environment to provide biomechanical stimulation to the cells within the scaffold, as well as to provide increased mixing of cell culture nutrient media for compositional homogeneity. It has been reported that modalities such as flow perfusion (van den Dolder et al., 2003) on BM cells has beneficial effects on proliferation and differentiation. The combination of high scaffold porosity and fluid flow minimizes diffusion constraints enhances differentiation of BMSC (Gomes et al., 2006) .
Collagen infusion and cell attachment
An important aspect of growing tissues in vitro has been for cells to be distributed homogeneously throughout the scaffold. This is a traditional consideration in animal cell culture to prevent heterogeneous localised cell growth and behaviour within the same growth environment. Methods such as dynamic perfusion (Li et al., 2001; Sodian et al., 2002; Wendt et al., 2003) , centrifugal force (Godbey et al., 2004; Yang et al., 2001) , rotation (Nasseri et al., 2003) , magnetic cell seeding (Perea et al., 2006) and stirring/ agitation (Kim et al., 1998a) have been used with some success. By using a collagen hydrogel cell delivery system, cells can be homogeneously and randomly distributed throughout a carrier matrix, and then infused into a scaffold. This is similar to the methods using fibrin gel to deliver cells to polyglycolic acid (PGA) scaffolds (Ameer et al., 2002) and Matrigel to deliver cells into collagen sponges (Radisic et al., 2003) . The use of a hydrogel infusion cell delivery vehicle is very useful for slow attaching primary cells because with standard cell attachment-dependent cell seeding techniques, the probability of losing cells from a porous synthetic scaffold with a short incubation period is high. It has been shown that using collagen microsponges increases cell seeding efficiency (Chen et al., 2004b) . Collagen is chemotactic and capable of stimulating further deposition of more matrix proteins (Kleinman et al., 1982) . Collagen also has the advantages of being a biological ECM and has a history of being used effectively in cardiovascular tissue engineering applications (Berglund et al., 2003; Imberti et al., 2002; Nasseri et al., 2003; Nillesen et al., 2007; Stegemann and Nerem, 2003a; . We synthesize and use kangaroo tail tendon as a source of collagen due to the high collagen yield per animal compared to other species. Traditionally, yield of collagen is extremely variable and dependent on the animal species and the age of the animal. Very low yields from human skin to higher yields in young rat skin of up to 60% have been reported (Bazin and Delaunay, 1976) with the richest sources of collagen fibres being from the skin and tendons of adult mammals (Steven, 1976) . However, if we consider total yield per animal tissue sample, especially in the face of animal ethics considerations, use of kangaroo tail is the most economical and high yield source. Also, use of relatively young animals is important as the proportion of insoluble collagen in most organs increases with age and can be affected by a number of physiological and pathophysiological situations (Deyl and Adam, 1976) . Figure 4 shows a porous 5wt%/vol poly DL-lactic-coglycolic acid (P(DL)LGA) (75:25) scaffold with 53-106µm pores that has been cut in half showing collagen fibres dispersed within the scaffold pores. Another benefit of using hydrogel cell delivery is that the hydrogel can also incorporate relevant growth factors to stimulate tissuespecific growth (Park et al., 2007) as well as for cell delivery. Figure 5 shows human microvascular cells SV-40 HMEC-1 showing clear alignment within a cell/collagen hydrogel/scaffold system.
Optimization of system parameters
Mass transfer has been a serious problem for thick tissues that do not attempt to include some sort of vascular supply or inherent channel structures throughout the scaffold to allow nutrients and wastes to diffuse. The use of macrolumens and other similar channels is an inherent structural method to aid in creating better access to nutrients for cells within a scaffold (Kaihara et al., 2000; Kannan et al., 2005; Kim et al., 1998b; Moldovan and Ferrari, 2002; Schantz et al., 2005; Shin et al., 2004; Vacanti et al., 2003) . With an optimal cell seeding and cell/scaffold culturing condition, such as dynamic cell seeding followed by bioreactor culture (Burg et al., 2000) , neovascularisation might be able to occur fast enough in highly porous scaffolds.
However there is a limit to this as there is an access gradient from the cells at the surface, which have the best access to nutrients, to the cells further away from the surface. However, it may be theorised that this may not be as big a disadvantage as it first seems. Since angiogenesis forms due to ischemia and nutrient/oxygen gradients in tissues, this nutrient/oxygen gradient in cell/matrix/scaffold systems may actually promote vessel in-growth and formation. The extent of mass transfer limitation can also be controlled to some extent by changing the concentration of the collagen hydrogel. Another method that we are testing is the use of anisotropic pore scaffolds which will minimize the tortuosity of the scaffold pore structure and therefore increase mass transfer. Figure 6 shows a scanning electron micrograph of equine BMSC cultured on one such anisotropic pore 5wt%/vol P(DL)LGA scaffold created using a TIPS method (Cao et al., 2003; Cao et al., 2006) . Clearly seen are multiple black pores on the surface of the cell/scaffold construct. We are comparing the cell viability and distribution characteristics of this design with the standard highly interconnected and porous isotropic scaffolds. Another option for increasing mass transfer of oxygen could be to use cell culture media additives such as perfluorocarbon to enhance the supply of oxygen to cells or the use of novel molecules for therapeutic angiogenesis (Sengupta et al., 2004) .
Optimization of the tools of tissue engineering used such as scaffolds, bioreactors and molecular and physical signalling is complex and requires a multidisciplinary approach and team of researchers and collaborators Mikos et al., 2006) . It is hoped that this current combinatorial approach will contribute to the research in bioengineered tissue vascularisation in vitro. One aspect that needs to be addressed further is the anisotropic nature of vascularisation and to design scaffolds and bioreactor systems that can mimic or nurture the potential to accommodate this anisotropy (Borselli et al., 2007; Lanza et al., 2006) . These biomechanical influences will in turn affect the remodelling of the vascular structures (Jones et al., 2006) . 
Conclusions
The current trend in vascularising bioengineered tissues is the integration of various parameters that have been observed from in vivo biological research and in vitro bioengineering research. These include combining design parameters of highly porous macro-and micro-channelled polymeric scaffolds, the use of biological ECM matrices such as collagen hydrogels, microvascular cells co-cultured with other cells or growth factors, and culturing the cell/ scaffold constructs in biomechanically dynamic environments. Microvascular cell co-culture with collagen hydrogel infusion in a highly interconnected and porous polymeric scaffold containing macro-lumens is one such integrated parameter system for creating a vascularized tissue. Benefits include the provision of a 3D matrix for cells to immediately adhere to within the scaffold, and gelling within a scaffold ensures cell entrapment within the scaffold. Potential drawbacks include a reduction of mass transfer ability to central regions of scaffold, but this factor may be beneficial given that angiogenesis occurs in response to ischemia. With a combinatorial approach, many growth parameters and interactions will need to be optimized before a true vascular analogue can be viably developed and maintained in vitro for tissue engineering. Finally, the ability to create a vascular analogue in vitro is very important to ensuring the viability and functionality of bioengineered organs, as is the capacity to connect to host vasculature upon implantation.
